LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions
The International Journal of Biochemistry & Cell Biology · 2026-10 · 199 · 106991
DOI: 10.1016/j.biocel.2026.106991 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2026-10. Verfasst von Wendong Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, China. Electronic address: chenwendong@ydyy.cn. Hauptthemen laut MEDLINE: Reperfusion Injury, Th17 Cells, Lipocalin-2, Heme Oxygenase-1. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Kunming Medical University.
Abstract (Originalsprache)
INTRODUCTION Intestinal ischemia-reperfusion (I/R) injury is a critical clinical condition involving oxidative stress, inflammation, and immune dysregulation, often leading to significant morbidity and mortality. This study investigates the protective mechanisms of Heme oxygenase-1 (Hmox1) against I/R-induced intestinal damage, focusing on its regulation of Th17/Treg cell balance via Lipocalin 2 (LCN2). MATERIAL AND METHODS Male wild-type mice and Hmox1-deficient mice were used to induce an intestinal I/R injury model. Histological analysis, ELISA, immunohistochemistry, immunofluorescence, flow cytometry, RT-qPCR, Western blotting, and RNA sequencing were used to evaluate intestinal injury, cytokine levels, and immune cell profiles. Transcriptomic analysis was conducted to identify differentially expressed genes and pathways involved in the immune response. Naive CD4+ T cells were isolated for in vitro differentiation experiments to analyze the role of LCN2 in Th17 and Treg differentiation under Hmox1-deficient conditions. RESULTS Hmox1 deficiency was associated with more severe intestinal mucosal injury, higher IL-6 and TNFα levels, enhanced Th17-associated responses, and reduced Treg-associated signals after I/R. Transcriptomic analysis indicated enrichment of IL-17, JAK-STAT, and TNFα signaling pathways. LCN2 expression increased after I/R and was further elevated in Hmox1-deficient I/R samples. In vitro, LCN2 knockdown enhanced Th17 polarization and further reduced Treg differentiation under oxidative/inflammatory stimulation, suggesting that LCN2 may participate in a compensatory immune-regulatory response. CONCLUSION These findings underline the crucial role of Hmox1 in preserving intestinal immune homeostasis during I/R injury and identify LCN2 as a candidate compensatory regulator of Th17/Treg balance under Hmox1-deficient conditions. LCN2 may therefore represent a potential target for non-Hmox1-dependent strategies to ameliorate intestinal I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, China. Electronic address: chenwendong@ydyy.cn.
- Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, China.
Förderung
- Kunming Medical University
Zitieren
APA
Chen, W., Li, J., Shao, J., Yang, M., Tan, Y., & Yang, W. (2026). LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions. The International Journal of Biochemistry & Cell Biology, 199, 106991. https://doi.org/10.1016/j.biocel.2026.106991
Vancouver
Chen W, Li J, Shao J, Yang M, Tan Y, Yang W. LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions. The International Journal of Biochemistry & Cell Biology. 2026;199:106991. doi:10.1016/j.biocel.2026.106991
BibTeX
@article{Chen2026,
author = {Chen, Wendong and Li, Junjie and Shao, Jianlin and Yang, Meixu and Tan, Ying and Yang, Wei},
title = {LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2026},
volume = {199},
pages = {106991},
doi = {10.1016/j.biocel.2026.106991}
}
EUVIMED